UBS Adjusts RemeGen's Price Target to HK$75.20 From HK$75.03, Keeps at Buy
UBS Adjusts RemeGen's Price Target to HK$75.20 From HK$75.03, Keeps at Buy
瑞银将RemeGen的目标股价从75.03港元调整至75.20港元,维持买入
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册